Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Diseases × figitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Recurrence 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Breast Diseases 1

Interventions

pyrotinib 2 Trastuzumab 2 Letrozole 2 Docetaxel 2 figitumumab 1 exemestane 1 Zoledronic Acid 1 Vinorelbine 1 Lapatinib 1 Everolimus 1 Drug Evaluation 1 Cyclophosphamide 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Pfizer

Phase 2 Withdrawn

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡